REFERENCES
1. Teoh D, Musa F, Salani R, Huh W,
Jimenez E. Diagnosis and Management of Adenocarcinoma in Situ: A Society
of Gynecologic Oncology Evidence-Based Review and Recommendations.
Obstet Gynecol. 2020 Apr;135(4):869-78.
2. Salani R, Puri I, Bristow RE.
Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278
patients evaluating the predictive value of conization margin status. Am
J Obstet Gynecol. 2009 Feb;200(2):182 e1-5.
3. Jiang Y, Chen C, Li L. Comparison
of Cold-Knife Conization versus Loop Electrosurgical Excision for
Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and
Meta-Analysis. PLoS One. 2017;12(1):e0170587.
4. Latif NA, Neubauer NL, Helenowski
IB, Lurain JR. Management of adenocarcinoma in situ of the uterine
cervix: a comparison of loop electrosurgical excision procedure and cold
knife conization. J Low Genit Tract Dis. 2015 Apr;19(2):97-102.
5. Bornstein J, Bentley J, Bosze P,
Girardi F, Haefner H, Menton M, et al. 2011 colposcopic terminology of
the International Federation for Cervical Pathology and Colposcopy.
Obstet Gynecol. 2012 Jul;120(1):166-72.
6. Arbyn M, Redman CWE, Verdoodt F,
Kyrgiou M, Tzafetas M, Ghaem-Maghami S, et al. Incomplete excision of
cervical precancer as a predictor of treatment failure: a systematic
review and meta-analysis. Lancet Oncol. 2017 Dec;18(12):1665-79.
7. Costales AB, Milbourne AM, Rhodes
HE, Munsell MF, Wallbillich JJ, Brown J, et al. Risk of residual disease
and invasive carcinoma in women treated for adenocarcinoma in situ of
the cervix. Gynecol Oncol. 2013 Jun;129(3):513-6.
8. Baalbergen A, Helmerhorst TJ.
Adenocarcinoma in situ of the uterine cervix–a systematic review. Int
J Gynecol Cancer. 2014 Nov;24(9):1543-8.
9. Kim ML, Hahn HS, Lim KT, Lee KH,
Kim HS, Hong SR, et al. The safety of conization in the management of
adenocarcinoma in situ of the uterine cervix. J Gynecol Oncol. 2011 Mar
31;22(1):25-31.
10. Andersen ES, Nielsen K.
Adenocarcinoma in situ of the cervix: a prospective study of conization
as definitive treatment. Gynecol Oncol. 2002 Sep;86(3):365-9.
11. Tan JHJ, Malloy MJ, Thangamani R,
Gertig D, Drennan KT, Wrede CD, et al. Management and long-term outcomes
of women with adenocarcinoma in situ of the cervix: A retrospective
study. Aust N Z J Obstet Gynaecol. 2020 Feb;60(1):123-9.
12. van Hanegem N, Barroilhet LM,
Nucci MR, Bernstein M, Feldman S. Fertility-sparing treatment in younger
women with adenocarcinoma in situ of the cervix. Gynecol Oncol. 2012
Jan;124(1):72-7.
13. Moyer VA. Screening for cervical
cancer: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2012 Jun 19;156(12):880-91, w312.
14. Costa S, Negri G, Sideri M,
Santini D, Martinelli G, Venturoli S, et al. Human papillomavirus (HPV)
test and PAP smear as predictors of outcome in conservatively treated
adenocarcinoma in situ (AIS) of the uterine cervix. Gynecol Oncol. 2007
Jul;106(1):170-6.
15. Costa S, Venturoli S, Negri G,
Sideri M, Preti M, Pesaresi M, et al. Factors predicting the outcome of
conservatively treated adenocarcinoma in situ of the uterine cervix: an
analysis of 166 cases. Gynecol Oncol. 2012 Mar;124(3):490-5.